HighTower Advisors’s Thermo Fisher Scientific TMO Stock Holding History

HighTower Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	-$10K	–	3534
2022 Q1	$10K	Buy	+3	New	+$1.72K	﹤0.01%	3217
2018 Q2	–	Sell	-1,500	Closed	-$39K	–	2371
2018 Q1	$39K	Sell	1,500 -3,500	-70%	-$735K	﹤0.01%	2028
2017 Q4	$25K	Buy	+5,000	New	+$958K	﹤0.01%	2146

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HighTower Advisors's TMO Position: Q2 2026 in Review

HighTower Advisors increased its Thermo Fisher Scientific (TMO) stake by 9.8% in Q2 2026, buying an estimated $6.81M and bringing the position to 159,181 shares worth $79.8M. The position accounts for 0.08% of the portfolio, ranked #255.

HighTower Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $113M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

HighTower Advisors held 159,181 shares of Thermo Fisher Scientific worth $79.8M as of Q2 2026.
HighTower Advisors bought 14,180 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.81M.
Thermo Fisher Scientific made up 0.08% of HighTower Advisors's portfolio in Q2 2026, its #255 holding.
HighTower Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
HighTower Advisors's Thermo Fisher Scientific position peaked at $113M in Q3 2024.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.